Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey


Demirci U., GÖKMEN E., Eralp Y., Gunduz S., SEZGİN GÖKSU S., KORKMAZ T., ...Daha Fazla

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 10 - 14 Aralık 2019, cilt.80 identifier